Gara Jalqabaatti › Saree Oljoo › Rhode Island
Qorannoo klinikaalii Saree Oljoo Rhode Island keessatti
Qorannoo 14 Saree Oljoo f Rhode Island keessatti hirmaatuu jiru.
Magaalota Rhode Island keessatti
Takkalaa qorannoo (Ingiliffa)
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
- Rhode Island Hospital, Providence
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 100 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05827081Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Kent Hospital, Warwick
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 40 hanga 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05334069A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
- Research Site, Providence
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06103864The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
- Smilow Cancer Hospital - Westerly, Westerly
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 60 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06377852A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
- Rhode Island Hospital, Providence
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT06492616Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
- Women and Infants Hospital, Providence
- Kent Hospital, Warwick
- Smilow Cancer Hospital Care Center - Westerly, Westerly
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 60 · Dubartoota · Haaromfame 02-Ful-2026 · NCT05879926ATEMPT 2.0: Adjuvant T-DM1 vs TH
- Smilow Cancer Hospital Care center at Westerly, Westerly
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 19-Hag-2026 · NCT04893109E-Mindfulness Approaches for Living After Breast Cancer
- Women and Infants Hospital, Providence
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 50 · Saalaa hunda · Haaromfame 04-Hag-2026 · NCT06748222Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- Women and Infants Hospital of Rhode Island, Providence
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Hag-2026 · NCT05579366A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Lifespan Cancer Institute - Rhode Island Hospital, Providence
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 8 fi ol · Saalaa hunda · Haaromfame 27-Ado-2026 · NCT05503797De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
- Rhode Island Hospital, Providence
- Women and Infants Hospital, Providence
- Kent Hospital, Warwick
- fi 1 dabalataa
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 50 hanga 70 · Saalaa hunda · Haaromfame 23-Elb-2026 · NCT04852887EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
- Women & Infants Hospital, Providence
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Ama-2026 · NCT06401421SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Providence
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Saalaa hunda · Haaromfame 28-Onk-2025 · NCT03452774Preventing Dato-DXd Associated Stomatitis With Dexamethasone Mouthwash, TROPION-DM
- Rhode Island and the Miriam Hospitals (Brown University Health), Providence
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Onk-2025 · NCT06974604Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.